LIAISON® PROLACTIN XT - COFEPRIS Registration 69R2020 SSA
Access comprehensive regulatory information for LIAISON® PROLACTIN XT (LIAISON® PROLACTIN XT) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 69R2020 SSA and manufactured by DIASORIN MÉXICO S.A. DE C.V.. The device was registered on February 05, 2020.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
ENSAYO IN VITRO PARA LA DETERMINACIÓNCUANTITATIVA DE PROLACTINA EN SUERO YPLASMA HUMANOS. EL ENSAYO DEBEREALIZARSE EN LA SERIE DE INSTRUMENTOSLIAISON® ANALYZER.
IN VITRO ASSAY FOR THE QUANTITATIVE DETERMINATION OF PROLACTIN IN HUMAN SERUM AND PLASMA. THE TEST SHOULD BE PERFORMED ON THE LIAISON® ANALYZER INSTRUMENT SERIES.